GSK CEO Witty to Retire

Mar 17, 2016

In the publication of its 2015 Annual Report to shareholders, GlaxoSmithKline announced that Sir Andrew Witty, CEO, will retire on March 31, 2017.

The Board will now conduct a formal search for a successor and will consider internal and external candidates for the role.

Witty will depart after 32 years with GSK, 10 of which were spent as Chief Executive Officer.

Read the GSK press release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments